ArticlePloS one2013

The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

Hubert Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.